Loading clinical trials...
Loading clinical trials...
The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes patients across ten countries across the world. Participants will be asked to give information ab...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT07112339 · Diabetes Mellitus, Type 2
NCT06329375 · Diabetes Mellitus, Type 2, Food Insecurity, and more
NCT06945406 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
NCT06959901 · Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention
Novo Nordisk Investigational Site
Algiers
Novo Nordisk Investigational Site
Batna City
Novo Nordisk Investigational Site
Constantine
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions